Take part in a paid clinical trial

This study is testing a new drug that is being developed to help people with inflammatory bowel disease (IBD), including ulcerative colitis and Crohn’s disease. While there are treatments already available, many of them only target one part of the immune system and don’t fully address all aspects of the disease. For example, current therapies often don’t treat the scarring (called fibrosis) that can build up in the bowel over time, and they may not fully heal the lining of the gut. Some treatments also stop working after a while or cause side effects that make long-term use difficult.

This study is investigating a potential treatment for people living with chronic kidney disease. This is a healthy volunteer Japanese participant study.

Chronic kidney disease (CKD) is a long-term condition where the kidneys gradually lose their ability to filter waste and excess fluids from the blood. This can lead to a buildup of toxins in the body, causing health issues such as fatigue, swelling, and high blood pressure. CKD often develops slowly over time, sometimes without noticeable symptoms in the early stages, and is commonly linked to conditions like diabetes and hypertension. While it cannot always be cured, early detection and management can help slow its progression, improve quality of life, and reduce the risk of serious complications. 

Join our flu vaccine study and get protected this season while helping advance important research. Influenza affects millions of people every year, and we’re working to understand how flu vaccines perform in real-world conditions.

By participating, you’ll receive your seasonal flu shot at no cost and contribute to research that could improve future vaccines and protect communities everywhere. It’s simple, sign up online, book your appointment, and get vaccinated while making a meaningful impact on public health. Current flu vaccines don’t always match the flu strains that are circulating, so their effectiveness can vary. Your involvement matters, and together we can build stronger protection against flu. 

The study drug is designed to help treat acne, which is a very common skin problem, especially for teenagers and young adults. Acne happens for several reasons, like oily skin (sebum), clogged pores, bacteria, and inflammation. 

This drug works by targeting and blocking an enzyme called fatty acid synthase (FASN). This enzyme (FASN) helps make fatty acids, which are a big part of the oil your skin produces. By blocking FASN, the study drug aims to reduce the amount of oil your skin makes, which could also help lower inflammation and other things that cause acne. 

Current acne treatments like antibiotics and hormonal therapies can work, but they often come with serious drawbacks. Antibiotics can lead to resistance and are usually only for short-term use. Hormonal treatments aren’t suitable for everyone and can have side effects. Other medications are very effective but can carry significant risks, like liver issues, and require strict monitoring. Because of these limitations, many patients either can’t use these treatments or don’t get the results they need. 

There’s a clear need for a new option that works well, is safe for long-term use, and doesn’t have the same restrictions. That’s why the study drug is being developed, to fill this gap and offer a better alternative for people struggling with acne.